The cAMP Pathway Amplifies Early MyD88-Dependent and Type i Interferon-Independent LPS-Induced Interleukin-10 Expression in Mouse Macrophages

Orna Ernst, Yifat Glucksam-Galnoy, Muhammad Athamna, Iris Ben-Dror, Hadar Ben-Arosh, Galit Levy-Rimler, Iain D.C. Fraser, Tsaffrir Zor*

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

16 Scopus citations


Interleukin-10 (IL-10) is a key anti-inflammatory cytokine, secreted by macrophages and other immune cells to attenuate inflammation. Autocrine type I interferons (IFNs) largely mediate the delayed expression of IL-10 by LPS-stimulated macrophages. We have previously shown that IL-10 is synergistically expressed in macrophages following a costimulus of a TLR agonist and cAMP. We now show that the cAMP pathway directly upregulates IL-10 transcription and plays an important permissive and synergistic role in early, but not late, LPS-stimulated IL-10 mRNA and protein expression in mouse macrophages and in a mouse septic shock model. Our results suggest that the loss of synergism is not due to desensitization of the cAMP inducing signal, and it is not mediated by a positive crosstalk between the cAMP and type I IFN pathways. First, cAMP elevation in LPS-treated cells decreased the secretion of type I IFN. Second, autocrine/paracrine type I IFNs induce IL-10 promoter reporter activity only additively, but not synergistically, with the cAMP pathway. IL-10 promoter reporter activity was synergistically induced by cAMP elevation in macrophages stimulated by an agonist of either TLR4, TLR2/6, or TLR7, receptors which signal via MyD88, but not by an agonist of TLR3 which signals independently of MyD88. Moreover, MyD88 knockout largely reduced the synergistic IL-10 expression, indicating that MyD88 is required for the synergism displayed by LPS with cAMP. This report delineates the temporal regulation of early cAMP-accelerated vs. late type I IFN-dependent IL-10 transcription in LPS-stimulated murine macrophages that can limit inflammation at its onset.

Original languageEnglish
Article number3451461
JournalMediators of Inflammation
StatePublished - 2019


FundersFunder number
National Institutes of Health
National Institute of Allergy and Infectious DiseasesZIAAI001107
European Commission021862
United States-Israel Binational Science Foundation2011360


    Dive into the research topics of 'The cAMP Pathway Amplifies Early MyD88-Dependent and Type i Interferon-Independent LPS-Induced Interleukin-10 Expression in Mouse Macrophages'. Together they form a unique fingerprint.

    Cite this